Skip To Content
Get Our Newsletter
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe

Tay-Sachs, MSUD Added to Social Security List

The Social Security Administration has added two genetic diseases that affect Ashkenazi Jews to its Compassionate Allowances list, expediting the awarding of disability aid to sufferers and their families.

Tay-Sachs and Maple Syrup Urine disease were added to the list effective March 1, 2010. They were among 38 diseases and cancers added to the original list of 50 conditions established by the Social Security Administration in 2008. Two other diseases that disproportionately affect Ashkenazi Jews, Canavan disease and Niemann-Pick disease type A, were on the original list.

Once a disease is identified as “one that is recognized on the Compassionate Allowances list, it goes on a fast-track and it can be approved within days,” according to a Social Security spokesperson.

Stefanie Putkowski, a clinical research assistant at the National Organization for Rare Diseases, said that sufferers from rare disorders can sometimes become embroiled in a long process where they are denied benefits. “This is a small blessing for parents or patients who need the disability assistance as soon as possible,” Putkowski said of the additions to the list.

According to the Social Security Administration, parents of disabled children under the age of 18 can apply for Supplemental Security Income and receive up to $674 a month, with the amount varying based upon the income of the parents and the number of individuals in the household.

Engage

  • SHARE YOUR FEEDBACK

  • UPCOMING EVENT

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free under an Attribution-Non Commercial-No Derivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit Foward and retain our pixel. See our full guidelines for more information.

To republish, copy the HTML, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, and credit to Foward. Have questions? Please email us at help@forward.com.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.